Introduction to cGMP in Biopharmaceutical Industry

Explore cGMP foundations for biologics in biopharmaceuticals, including regulatory GXP, GMP, GLP, GDP, and GCP frameworks; learn how biologics like monoclonal antibodies and gene therapies shape modern drug development.

Explore how a quality management system serves as a pharmaceutical quality framework—not regulatory compliance—clarifying its relation to cGMP and GMP while detailing QA, QC, and essential process tools.

Discover core quality management system tools, including capa for root-cause investigation and verification, Ishikawa diagram categories like equipment, process, and people, risk assessment, audits, oos investigations, and change control.

this lecture presents quality by design (qbd) as a systematic biomanufacturing development approach, emphasizing predefined objectives, product and process understanding, quality target product profile, and risk-based control.

Explore quality by design concepts in biopharmaceutical manufacturing, linking critical quality attributes to their controlling critical process parameters and critical material attributes to ensure product quality.

Use design of experiments (DoE) with Jump JMP to apply full factorial, fractional factorial, and central composite designs for optimizing oil content, drug loading, emulsification time, and droplet size.

Assess risk across QBD life cycle with FMEA, risk ranking, and preliminary hazard analysis, then craft a validation master plan and apply PAT for real-time release and monitoring with spectroscopy.

Learn gmp and gxp, and how regulators set standards while execution varies by company. Validate processes to embed quality, covering people, product, process, procedure, and promises for traceability and accountability.

Learn aseptic processing by sterilizing product and packaging separately, then bringing them together in a sterilized environment to prevent contamination, and explore contamination control strategies and essential documentation for biopharmaceutical manufacturing.

Practice good documentation practice (GDP) through the Alcoa principles—attribute, legible, contemporaneous, original, and accurate—using indelible ink, legible entries, signatures, and compliant amendments to prevent FDA warning letters.

Explore premises in cGMP biopharma, covering equipment, facility, and HVAC; ensure cleanable surfaces, laminar flow, and cross-contamination prevention, with grade/ISO standards for gowning and changeover.

Train personnel to master aseptic technique and isokinetic movement to minimize contamination in clean rooms, stay aware of the cGMP standard, and maintain rigorous hand and glove sanitization.

Explore the basic background of the biopharmaceutical industry, the QMS, the five parts of cGMP, CAPA, audits, change control, and QBD, with GDP and air and water requirements.